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Introduction. The aim of the exracranial stereotactic technique (SBRT) is the administration in few sessions of high doses of
radiation to a reduced volume adjacent to critical organs. This technique needs a very precise immobilization and a way to
reproduce it daily with ease.
Target. To explain the different immobilization systems used in radiation oncology service ICODuran Reynals since this technique
was ﬁrst used until the latest technique used today.
Methodology. We started using the technique in 2008. We have used several immobilization procedures since then. And each
treatment session quality control images were taken and analyzed to measure the deviations occurred from the longitudinal,
lateral and vertical isocenter.
Conclusions. We have observed that with the different locking systems used during the time period of 2008–2013 we were able
to gradually reduce the deviation from the isocenter. In conclusion, a good immobilization procedure assures us a more precise
treatment consisting of smaller ﬁelds and closer to organs at risk.
http://dx.doi.org/10.1016/j.rpor.2013.03.552
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Objective. To introduce the technique of SBRT in radiotherapy service.
Introduction. Extracranial stereotactic radiation therapy is a formof high-precision radiotherapy treatment using hypofractionated
ablative radiation dose, 1–5 fractions, stereotactic-techniques with 3D conformal radiotherapy (3D-CRT) or intensity modulated
radiotherapy (IMRT), image-guided-radiotherapy (IGRT) before each fraction.
Methods. In March 2012 we began the implementation of SBRT. Patient were selected if oligometástasis (controlled primary
tumor and metastasis in numbers ≤3, located in the same), life-expectancy>6 months and -PS<2. The process comprising:
1. Interventional Radiology Department inserts a ﬁducial-marker (Visicoil®, all-CT except guided ultrasound in 2 cases). Is
placed at a distance<5 cm of the metastatic lesion and the patient remains under observation 24h if metastases are lung
(no-pneumothorax), otherwise referred to its home at 6-o’clock insertion. 2. Immobilization abdominal-compressor system
Body-Pro-Lock® indexed to the treatment-table and the marking and tattooing TAC-referenced. 3. Acquisition in 4DPET/CT with
Philips-Gemini-TF gating to liver damage or CT-if pulmonary gating, both with abdominal compression system. 4D-acquired in
both the PET and the CT. Perform a takeover of CT in a situation of normal breathing. 4D acquisitions are used-to contour the
GTV-following the movement of the respiratory cycle. 4. Fuse with the planning-system PhilipsPinnacle8.0 with CT-obtained in
normal breathing. This acquisition is for outline planning treatment and risk-organs. 5. We determined ITV-and-PTV margin
expansion ranged from 3 to 5mm. 6. Treatment given in Siemens-Linear-Accelerator, -with built-imaging-equipment (ExacTrac)
being-acquired stereoscopic images that are fused to the DRR-planning and adjusts automatically to the correct position.
Results. Since March 2012 we have treated-6 patients-(4 liver-metastases and 3 lung; 1 patient twice, lung and liver-metastases),
dose 36–12Gy/session, 3 sessions/week (except the ﬁrst patient: 50–5Gy −10 sessions on alternate days). One-patient-died due
to disease progression and 5 remaining stable. Immediate-tolerance: acute toxicity, vs. 3 CTC criteria, G2-asthenia in 2 patients
and no toxicity in the rest.
Conclusions. SBRT treatment modality is a high precision, which is evolving. Its effectiveness is proven in lung carcinoma non-
small-cell, lung metastases, liver and spine. Our initial experience conﬁrms the feasibility of its application and usefulness in
our midst.
http://dx.doi.org/10.1016/j.rpor.2013.03.553
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Objective. Analyze the results of single dose RS to spinal metastases without spinal cord compression.
Methods. In our institution vertebral metastasis treatment is performed by a Novalis® LINAC (BrainLab, Germany). The Novalis®
utilizes image registration of anatomical structures such as vertebral bone in a non-invasive procedure. Images are taken on the
simulation CT, with body vacuum-bag, using infrared external ﬁducials on the patient’s skin, CT images are contouring module
on planning system (iPlan-Net.v5.1®) fussed with a volumetric T1 and T2 weighted MRI. The external ﬁducials are tracked by the
